The recombinant drug industry is growing at almost 20% rate in India. The long term growth of this sector depends upon the innovation as well as competition and market. The structure, conduct and performance of firms in market plays a very important ro…

This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology
Commercial biotechnology in Latin America: Current opportunities and challenges
Go to paperABSTRACT: The unparalleled growth of commercial biotechnology in…

This chart shows the companies with the successful drug patent challenges from last year. The most successful drug patent challengers

I will be helping judge the AUTM Venture Forum again this year. The competition features a $10,000 prize for the

This guest post is from the BiotechBlog Intern,  Fintan Burke. Fintan is a student at the School of Biotechnology at Dublin

This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology
A brave new Europe with the introduction of the EU Clinical Trials Directive: Impact upon the pharma industry and academic research with special emphasis on…

This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology
Intellectual property: The driving force for growth and funding
Go to paperABSTRACT: For most ‘bio-entrepreneurs’ the science is the easy part — leveragin…

Made available by the elective open access option at the Journal of Commercial Biotechnology, this paper is free to view without subscription: The

This paper is part of the free Open Access archive of the Journal of Commercial Biotechnology
Fostering the process of adoption of personalised medicine: A matter of communication or a matter of cost?
Go to paperABSTRACT: Pharmacogenetics, along with…